主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RVMD
#452
Revolution Medicines, Inc. Common Stock
149.590
0
USD
+1.75%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+1.75%
每月变动
+54.86%
6个月变化
+170.02%
年变化
+170.02%
前一天收盘价
147.010
0
开盘价
149.510
0
买价
卖价
最低价
148.170
0
High
150.389
0
交易量
2 860
市场
股票
医疗保健
RVMD
展开完整图表
Financials
概览
声明
统计
每季度
年度
利润表
资产负债表
现金流
值
2020
2021
2022
2023
2024
2025
总资产
567.4 M
737.99 M
811.93 M
2.06 B
2.56 B
2.35 B
负债总额
92.72 M
135.42 M
126.74 M
235.51 M
293.1 M
723.21 M
权益总额
474.68 M
602.57 M
685.19 M
1.83 B
2.27 B
1.63 B
负债及股东权益总额
567.4 M
737.99 M
811.93 M
2.06 B
2.56 B
2.35 B
总债务
—
—
—
—
—
—
净债务
—
—
—
—
—
—
新闻
Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ)
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
Stocks Settle Higher in Hopes for an Agreement to End the Iran War
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)
Stocks Recover as Oracle Leads Software Companies Higher
Stocks Retreat as US Set to Blockade the Strait of Hormuz
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?
Harbor Health Care ETF Q4 2025 Portfolio Review